Immuron Limited (ASX:IMC)
Australia · Delayed Price · Currency is AUD 0.0300
-0.0030 (-9.09%)
Jun 19, 2026, 2:08 PM AEST
Immuron Market Cap
Immuron has a market cap or net worth of 9.8 million as of June 18, 2026. Its market cap has decreased by -30.06% in one year.
Market Cap
9.80M
Enterprise Value
8.20K
Revenue
7.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since September 14, 1999, Immuron's market cap has decreased from 37.31M to 9.80M, a decrease of -73.73%. That is a compound annual growth rate of -4.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 9.80M | -16.37% |
| Dec 31, 2025 | 11.72M | -35.27% |
| Dec 30, 2024 | 18.10M | 3.20% |
| Dec 29, 2023 | 17.54M | -10.47% |
| Dec 30, 2022 | 19.59M | -14.00% |
| Dec 31, 2021 | 22.78M | -56.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteomics International Laboratories | 19.82M |
| Opthea | 19.15M |
| Argenica Therapeutics | 14.13M |
| Cambium Bio | 11.34M |
| Invex Therapeutics | 9.77M |
| Vectus Biosystems | 9.22M |
| AdAlta | 7.97M |
| Acrux | 7.70M |